Literature DB >> 31609187

Effect of Psychotherapy for Borderline Personality Disorder on Quality of Life: A Systematic Review and Meta-Analysis.

Farid Chakhssi1, J Monique Zoet1, Jeanine M Oostendorp1, Matthijs L Noordzij2, Marion Sommers-Spijkerman2.   

Abstract

Whereas several meta-analyses have shown that psychotherapy is effective for reducing borderline personality disorder (BPD) pathology, the overall impact of psychotherapy for BPD on quality of life (QoL) remains as yet unclear. Because impaired QoL is associated with poor long-term outcomes after therapy for BPD, this seems a timely and relevant issue. The authors conducted a systematic review and meta-analysis of randomized controlled trials of psychotherapies for adults diagnosed with BPD that reported results of QoL at posttreatment. Fourteen trials were included (1,370 individuals with BPD). Psychotherapies for BPD relative to control conditions showed significant effect sizes for QoL (Cohen's d = 0.31; 95% CI [0.18, 0.44]), and for BPD pathology (d = 0.43; 95% CI [0.23, 0.64]). The effect on QoL was not significantly moderated by the effect on BPD pathology. Psychotherapies for BPD have a positive effect on QoL of patients with BPD. However, more studies are needed to examine the impact of psychotherapy on QoL and long-term outcome, including recovery.

Entities:  

Keywords:  borderline personality disorder; meta-analysis; psychotherapy; quality of life; systematic review

Year:  2019        PMID: 31609187     DOI: 10.1521/pedi_2019_33_439

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  2 in total

1.  Benefits of Art Therapy in People Diagnosed With Personality Disorders: A Quantitative Survey.

Authors:  Suzanne Haeyen; Farid Chakhssi; Susan Van Hooren
Journal:  Front Psychol       Date:  2020-04-15

2.  Towards optimal treatment selection for borderline personality disorder patients (BOOTS): a study protocol for a multicenter randomized clinical trial comparing schema therapy and dialectical behavior therapy.

Authors:  Carlijn J M Wibbelink; Arnoud Arntz; Raoul P P P Grasman; Roland Sinnaeve; Michiel Boog; Odile M C Bremer; Eliane C P Dek; Sevinç Göral Alkan; Chrissy James; Annemieke M Koppeschaar; Linda Kramer; Maria Ploegmakers; Arita Schaling; Faye I Smits; Jan H Kamphuis
Journal:  BMC Psychiatry       Date:  2022-02-05       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.